EMEA press release: CHMP adopted a positive opinion for pandemic influenza vaccine H5N1 (Celvapan)
COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE SUMMARY OF POSITIVE OPINION for CELVAPAN Common Name: Pandemic Influenza Vaccine (H5N1 whole virion, Vero cell derived, inactivated) On 18 December 2008 the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of a marketing authorisation for the medicinal product Celvapan, 7.5 […]